Everence Capital Management Inc Guardant Health, Inc. Transaction History
Everence Capital Management Inc
- $1.67 Billion
- Q3 2025
A detailed history of Everence Capital Management Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 4,080 shares of GH stock, worth $400,411. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,080
Previous 4,080
-0.0%
Holding current value
$400,411
Previous $212,000
20.28%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding GH
# of Institutions
429Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$1.19 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.1 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$503 Million0.25% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$488 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$417 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $10B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...